Brazilian Journal of Cardiovascular Surgery, 2023 · DOI: 10.21470/1678-9741-2021-0548 · Published: January 1, 2023
This study investigates the potential of ginsenoside Rd, a component of ginseng, to protect the spinal cord from damage caused by interrupted blood flow during surgery. Researchers used a rat model to mimic spinal cord ischemia-reperfusion injury, which can lead to paraplegia. The study found that rats pretreated with ginsenoside Rd experienced less motor deficit, had more surviving motor neurons, reduced oxidative stress, and decreased inflammation in their spinal cords compared to a control group. This suggests ginsenoside Rd may have neuroprotective effects. These findings indicate that ginsenoside Rd pretreatment could be a promising strategy to prevent spinal cord damage in patients undergoing thoracoabdominal aortic surgery, a procedure known to risk disrupting blood flow to the spinal cord.
Ginsenoside Rd pretreatment may be a valuable preventive measure to reduce the risk of spinal cord ischemia-reperfusion injury during thoracoabdominal aortic surgery.
Ginsenoside Rd could be further explored as a therapeutic agent to mitigate spinal cord damage resulting from ischemia-reperfusion injury, potentially improving patient outcomes.
Further research is warranted to determine the optimal dosage and timing of ginsenoside Rd administration to maximize its neuroprotective effects.